Search results
New customised drug developed to fight aggressive breast cancer
Investing.com· 4 days agoNew customised drug developed to fight aggressive breast cancer
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 2 days ago(Nasdaq: VSTM) announced it planned to apply for accelerated approval of its experimental...
Former NC GOP leader: State treasurer must reverse course on weight loss drugs | Opinion
Charlotte Observer via Yahoo News· 24 minutes agoBut private insurers and other parties already negotiate bulk prices with drug makers, often...
New Gel Preserves Breast Cancer Tissue For Enhanced Drug Testing
The Longview News-Journal· 6 days agoResearchers have achieved a breakthrough in breast cancer treatment by keeping breast cancer tissue...
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential...
Fortune via Yahoo Finance· 10 hours agoGLP-1 receptor agonists made the shortlist after SGLT2 inhibitors, metformin and the osteoporosis ...
Scientists create tailored drug for aggressive breast cancer
Medical Xpress· 4 days agoScientists have used breast cancer cells' weakness against themselves by linking a tumor-selective...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 3 days agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest...
Medical Xpress· 2 days agoLooking to identify new vulnerabilities in this type of cancer that could lead to improved...
Docs support drug regulator’s move to withdraw Olaparib for some cancer patients
Investing.com· 3 days agoNew Delhi, May 23 (IANS) Oncologists on Thursday supported the Drug Controller General of India's...
FDA withdraws Helsinn’s accelerated approval for cancer drug after company’s request
Endpoints News· 6 days agoThe FDA on Friday withdrew an accelerated approval for Helsinn’s bile duct cancer drug, two years...